Ll. Simpson et al., CHELATION OF ZINC ANTAGONIZES THE NEUROMUSCULAR BLOCKING PROPERTIES OF THE 7 SEROTYPES OF BOTULINUM NEUROTOXIN AS WELL AS TETANUS TOXIN, The Journal of pharmacology and experimental therapeutics, 267(2), 1993, pp. 720-727
Botulinum neurotoxin types A, B (unactivated and activated), C, D, E,
F and G, as well as tetanus toxin, paralyzed transmission in mouse phr
enic nerve-hemidiaphragm preparations. Toxin-induced blockade of trans
mission was antagonized by chelators [e.g., ethylenediamine tetraaceti
c acid, tetrakis(2-pyridylmethyl) ethylenediamine or diethylene-triami
nepentaacetic anhydride], but this effect was dependent on incubation
conditions. Pretreatment of toxin with chelators failed to produce ant
agonism, but pretreatment of tissues did produce antagonism. Of the va
rious chelators tested, tetrakis(2-pyridylmethyl)ethylenediamine produ
ced the greatest effect. Antagonism of toxin-induced neuromuscular blo
ckade could be partially reversed by washing chelators from tissues an
d could be fully reversed by adding an excess of zinc. The ability of
chelators to antagonize clostridial neurotoxins was specific and did n
ot extend to phospholipase A2 neurotoxins. Ligand-binding studies with
radioiodinated toxin and brain membrane preparations showed that chel
ators did not antagonize toxicity by inhibiting toxin association with
receptors. Similarly, pharmacological experiments with unlabeled toxi
n- and type-specific antibodies demonstrated that chelators did not ac
t by blocking receptor-mediated internalization of toxin. The chelator
s appeared to exert their effects by antagonizing the intracellular ac
tions of clostridial neurotoxins. Electrophysiological studies showed
that chelators, at concentrations relevant to antagonism of botulinum
neurotoxin and tetanus toxin, did not enhance transmitter release. The
refore, the chelators appeared to work by inhibiting the proposed zinc
endoprotease activity of clostridial neurotoxins. The results indicat
e that there are three classes of universal antagonists that delay or
abolish the actions of all serotypes of botulinum neurotoxin and tetan
us toxin: 1) lectins with affinity for sialic acid antagonize binding,
2) drugs that block (e.g., bafilomycin) or reverse (e.g., methylamine
hydrochloride) acidification of endosomes antagonize internalization
and 3) drugs that chelate zinc antagonize intracellular expression of
toxicity. The three classes of universal antagonists can be used in co
mbination to produce striking reductions in the apparent potency of cl
ostridial neuro toxins.